Artificial Intelligence Powered Chatbots in Mental Health: Exploring Innovations for Early Detection and Personalized Treatment
DOI:
https://doi.org/10.35845/abms.2024.2.348Keywords:
artificial intelligence, chatbots, cognitive-behavioral therapy, psychiatric diseasesAbstract
OBJECTIVE: The aim of this review article is to analyse the use of artificial intelligence chatbots in mental health and to outline its use in the early detection and treatment of various psychiatric disorders affecting mental health. The article also aims to provide its practical applications and insights into future research directions.
METHODOLOGY: This study employed a systematic review methodology, searching major medical and psychological databases (PubMed, PsycINFO, Embase, and Cochrane Library) using keywords and MeSH terms related to artificial intelligence chatbots, mental health, and artificial intelligence in mental health. The focus was on clinical trials, meta-analyses, systematic reviews, and observational studies, while excluding animal studies, case reports, and non-peer-reviewed articles.
RESULTS: The review yielded a total of 75 studies that investigated the role of artificial intelligence (AI)-powered chatbots in mental health care, comprising 25 clinical trials, 10 meta-analyses, 15 systematic reviews, and 25 observational studies. It was found that AI-powered chatbots have the potential to revolutionize mental health care by providing accessible and efficient support, but concerns around data privacy and security must be addressed.
CONCLUSION: AI-powered chatbots have the capacity and ability to provide support and help to those suffering from various mental health issues. On the other hand, concerns exist pertaining to an individual’s privacy and personal data. Further research is needed to conduct studies to address its drawbacks.
References
Ebert DD, Van Daele T, Nordgreen T, Karekla M, Compare A, Zarbo C, Brugnera A, Øverland S, Trebbi G, Jensen KL, Kaehlke F. Internet-and mobile-based psychological interventions: applications, efficacy, and potential for improving mental health. European Psychologist. 2018 May 14.
Fitzpatrick KK, Darcy A, Vierhile M. Delivering cognitive behavior therapy to young adults with symptoms of depression and anxiety using a fully automated conversational agent (Woebot): a randomized controlled trial. JMIR mental health. 2017 Jun 6;4(2):e7785.
Leertouwer I, Cramer A, Vermunt J, Schuurman NK. A Review of Explicit and Implicit Assumptions When Providing Personalized Feedback Based on EMA Data.
Balcombe L, De Leo D. Digital mental health challenges and the horizon ahead for solutions. JMIR Mental Health. 2021 Mar 29;8(3):e26811.
D'alfonso S, Santesteban-Echarri O, Rice S, Wadley G, Lederman R, Miles C, Gleeson J, Alvarez-Jimenez M. Artificial intelligence-assisted online social therapy for youth mental health. Frontiers in psychology. 2017 Jun 2;8:796.
Carstensen LL, DeLiema M. The positivity effect: A negativity bias in youth fades with age. Current opinion in behavioral sciences. 2018 Feb 1;19:7-12.
Baumel A, Muench F, Edan S, Kane JM. Objective user engagement with mental health apps: systematic search and panel-based usage analysis. Journal of medical Internet research. 2019 Sep 25;21(9):e14567.
Graham S, Depp C, Lee EE, Nebeker C, Tu X, Kim HC, Jeste DV. Artificial intelligence for mental health and
mental illnesses: an overview. Current psychiatry reports. 2019 Nov;21:1-8.
Lee EE, Torous J, De Choudhury M, Depp CA, Graham SA, Kim HC, Paulus MP, Krystal JH, Jeste DV. Artificial intelligence for mental health care: clinical applications, barriers, facilitators, and artificial wisdom. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. 2021 Sep 1;6(9):856-64.
Vaidyam AN, Wisniewski H, Halamka JD, Kashavan MS, Torous JB. Chatbots and conversational agents in mental health: a review of the psychiatric landscape. The Canadian Journal of Psychiatry. 2019 Jul;64(7):456-64.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Mohammad Ali, Urbah Viqar
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.